Overview
Just - Evotec Biologics is a CDMO providing end-to-end development and cGMP manufacturing for antibodies, next-generation biologics, and biosimilars. They specialize in continuous manufacturing technology to reduce costs and improve access to affordable biotherapeutics, with facilities in Seattle, Redmond (US), and Toulouse (France). Services span discovery using AI platforms like J.HAL and J.MD, process development, and clinical-to-commercial production up to 2,000+ kg/year.
Frequently asked questions
- What biologics manufacturing capabilities does Just - Evotec Biologics offer?
- They provide cGMP biomanufacturing from early clinical to commercial scale, including continuous manufacturing at J.POD facilities in Redmond (up to 2,000+ kg/year), J.PLANT Seattle for early-phase, and a new site in Toulouse, France, with process development under one roof.
- What discovery and development technologies do they use?
- Just - Evotec Biologics employs AI-driven platforms like J.HAL for antibody discovery, J.MD for molecular design optimization, and additional capabilities from Evotec including phage display and B-cell technologies for improved developability and manufacturability.
- What are their regulatory and geographic capabilities?
- They offer cGMP-compliant manufacturing at US sites (Seattle, Redmond) and Europe (Toulouse, France), leveraging continuous manufacturing for cost reduction to $50/gram or lower, with global network support through Evotec for integrated biologics activities.